Literature DB >> 20036459

Human papillomavirus and p16 expression in inverted papillomas of the urinary bladder.

Victor E Gould1, Markus Schmitt, Svetlana Vinokurova, Vijaya B Reddy, Pincas Bitterman, Angel Alonso, Paolo Gattuso.   

Abstract

Human Papillomaviruses (HPVs) have been found in association with benign and malignant growth of epithelia. The cell cycle inhibitor p16(Ink4a) has been shown to be overexpressed in HPV-positive cervical pre-malignant and malignant lesions, probably as a result of pRB targeting by the viral E7 protein. Inverted papillomas of the urinary bladder are epithelial tumors considered to be of benign nature. In this report we analyze the expression of p16(Ink4a) and the presence of HPV sequences in inverted papillomas and in non-tumoral bladder controls. Our results show no association of HPV infection and inverted papillomas. Further, no correlation between p16 overexpression and HPV positivity was found. We conclude that HPV does not play an indispensable role in the development of urinary bladder inverted papillomas and that overexpression of p16(Ink4a) does not correlate with HPV infection in these tumors. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20036459     DOI: 10.1016/j.canlet.2009.11.022

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

1.  Human papillomavirus infection and bladder cancer risk: a meta-analysis.

Authors:  Ni Li; Lin Yang; Yawei Zhang; Ping Zhao; Tongzhang Zheng; Min Dai
Journal:  J Infect Dis       Date:  2011-07-15       Impact factor: 5.226

2.  Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blot.

Authors:  Renate Pichler; Wegene Borena; Georg Schäfer; Claudia Manzl; Zoran Culig; Sebastian List; Sabrina Neururer; Dorothee Von Laer; Isabel Heidegger; Helmut Klocker; Wolfgang Horninger; Hannes Steiner; Andrea Brunner
Journal:  World J Urol       Date:  2015-03-19       Impact factor: 4.226

3.  Inverted papilloma of the ureter: study of a rare case with emphasis on clinicopathologic implications.

Authors:  Nikolaos Mertziotis; Diomidis Kozyrakis; Andreas Petrolekas; Maria Terzi; Nikiforos Kapranos
Journal:  Can Urol Assoc J       Date:  2012-12       Impact factor: 1.862

Review 4.  HPV infection in urology practice.

Authors:  Mehmet Sarier; Ali Murat Ceyhan; Nevgun Sepin; Esin Ozel; Mehmet Murat Inal; Erdal Kukul; Ahmet Soylu
Journal:  Int Urol Nephrol       Date:  2019-10-03       Impact factor: 2.370

5.  Coincidence of HPV11-Positive Urethral Condyloma Acuminatum and HPV-Negative Multiple Bladder Papillomas in a Female.

Authors:  Natsuko Nakazaki; Masayoshi Zaitsu; Koji Mikami; Shunsuke Yui; Ayumi Kanatani; Takushi Nakatani; Akiko Ito; Yuta Takeshima; Akiko Tonooka; Hideaki Oka; Tomoko Miki; Takumi Takeuchi
Journal:  Case Rep Med       Date:  2012-03-04

6.  Meta-analysis of studies analyzing the role of human papillomavirus in the development of bladder carcinoma.

Authors:  Antonio Jimenez-Pacheco; Manuela Exposito-Ruiz; Miguel A Arrabal-Polo; Alfonso J Lopez-Luque
Journal:  Korean J Urol       Date:  2012-04-18

7.  Innumerable Condyloma Acuminatum Tumors of the Bladder.

Authors:  Alexandra J Murray; Trinity J Bivalacqua; Nikolai A Sopko
Journal:  Urol Case Rep       Date:  2017-04-01

8.  HRAS mutations are frequent in inverted urothelial neoplasms.

Authors:  Andrew S McDaniel; Yali Zhai; Kathleen R Cho; Saravana M Dhanasekaran; Jeffrey S Montgomery; Ganesh Palapattu; Javed Siddiqui; Todd Morgan; Ajjai Alva; Alon Weizer; Cheryl T Lee; Arul M Chinnaiyan; Michael J Quist; Catherine S Grasso; Scott A Tomlins; Rohit Mehra
Journal:  Hum Pathol       Date:  2014-06-18       Impact factor: 3.466

9.  Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection.

Authors:  Julie Steinestel; Marcus V Cronauer; Johannes Müller; Andreas Al Ghazal; Peter Skowronek; Annette Arndt; Klaus Kraft; Mark Schrader; Andres J Schrader; Konrad Steinestel
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

10.  Salivary High-Risk Human Papillomavirus (HPV) DNA as a Biomarker for HPV-Driven Head and Neck Cancers.

Authors:  Chameera Ekanayake Weeramange; Zhen Liu; Gunter Hartel; Yinan Li; Sarju Vasani; Julian Langton-Lockton; Lizbeth Kenny; Luc Morris; Ian Frazer; Kai D Tang; Chamindie Punyadeera
Journal:  J Mol Diagn       Date:  2021-07-27       Impact factor: 5.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.